Table 4. Clinical performance of the cervical cancer screening tests using a CIN3+ threshold.

	VIA	DC	Xpert HPV	OncoE6
True positive	12	15	18	8
False positive	17	24	76	3
True negative	162	155	102	176
False negative	7	5	2	12
Sensitivity (95% CI)	63% (38-84%)	75% (51-91%)	90% (68-99%)	40% (19-64%)
Specificity (95% CI)	91% (85-94%)	87% (81-91%)	57% (48-65%)	98% (95-100%)
PPV (95% CI)	41% (24-61%)	39% (23-55%)	19% (12-29%)	73% (39-94%)
NPV (95% CI)	96% (92-98%)	97% (93-99%)	98% (93-100%)	94% (89-97%)
PLR (95% CI)	7 (4-12)	6 (4-9)	2 (2-3)	24 (7-83)
NLR (95% CI)	0.4 (0.2-0.7)	0.3 (0.1-0.6)	0.2 (0.1-0.6)	0.6 (0.4-0.9)
OR (95% CI)	16 (6-46)	19 (7-56)	12 (3-.)	39 (10-154)

VIA: visual inspection with acetic acid; DC: digital cervicography; 95% CI: 95% confidence interval; PPV: positive predictive value; NPV: negative predictive value; PLR: positive likelihood ratio; NLR: negative likelihood ratio; OR: odds ratio